Evidence map›Paper›PMID 36186629›Full record

ArticleFrontiers in pediatrics2022

Potential role of

Alex Jenei, Gábor Bedics, Dániel J Erdélyi, Judit Müller, Tamás Györke, Csaba Bödör, Ágota Szepesi

Abstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alex JeneiDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Gábor BedicsDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Dániel J Erdélyi2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
Judit Müller2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
Tamás GyörkeDepartment of Nuclear Medicine Semmelweis University, Budapest, Hungary.
Csaba BödörDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Ágota SzepesiDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 5-year-old male child was diagnosed with interdigitating dendritic cell sarcoma (IDCS) during his maintenance therapy for B-cell precursor acute lymphoblastic leukemia (B-ALL). Multiplex lymph node involvements of the neck were found by positron emission tomography CT (PET-CT). Treatments, including surgical and chemotherapy, resulted in complete remission. Four years later, systemic bone infiltration was discovered. Surgical resection of the IV rib and intensive chemotherapy led to a complete morphological remission, and allogeneic bone marrow transplantation was performed. Comprehensive genomic profiling of the formalin fixed the tumor tissue, and the cryopreserved leukemic cells revealed several common alterations and divergent clonal evolution with a novel

Indexed as

interdigitating dendritic cell sarcomaMAP2K1 mutationpediatric sarcomasecondary malignant histiocytosistrans-differentiation

Identifiers

PMID36186629
PMCPMC9523154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.